-
1
-
-
0344825229
-
Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: Review of the evidence and methodological considerations
-
Rihal CS, Raco DL, Gersh BJ, et al. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 2003;108:2439-45.
-
(2003)
Circulation
, vol.108
, pp. 2439-2445
-
-
Rihal, C.S.1
Raco, D.L.2
Gersh, B.J.3
-
2
-
-
0035849152
-
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
-
Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
-
(2001)
N Engl J Med
, vol.344
, pp. 1117-1124
-
-
Serruys, P.W.1
Unger, F.2
Sousa, J.E.3
-
3
-
-
4644317869
-
Wann sind Drug-eluting Stents als wirksam zu bezeichnen? Eine kritische Analyse der aktuellen Datenlage
-
Silber S. Wann sind Drug-eluting Stents als wirksam zu bezeichnen? Eine kritische Analyse der aktuellen Datenlage. Z Kardiol 2004;93:649-63.
-
(2004)
Z Kardiol
, vol.93
, pp. 649-663
-
-
Silber, S.1
-
4
-
-
4344595775
-
Sirolimus eluting stent implantation for patients with multivessel disease: Rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)
-
Serruys PW, Lemos PA, van Hout BA. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart 2004;90:995-8.
-
(2004)
Heart
, vol.90
, pp. 995-998
-
-
Serruys, P.W.1
Lemos, P.A.2
Van Hout, B.A.3
-
5
-
-
3543064732
-
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: Results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions (SIRIUS) trial
-
Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004;110:508-14.
-
(2004)
Circulation
, vol.110
, pp. 508-514
-
-
Cohen, D.J.1
Bakhai, A.2
Shi, C.3
-
6
-
-
3543096366
-
Economics of sirolimus-eluting stents: Drug-eluting stents have really arrived
-
Weintraub WS. Economics of sirolimus-eluting stents: drug-eluting stents have really arrived. Circulation 2004;110:472-4.
-
(2004)
Circulation
, vol.110
, pp. 472-474
-
-
Weintraub, W.S.1
-
7
-
-
2342423261
-
Economic impact of drug-eluting stents on hospital systems: A disease-state model
-
Kong DF, Eisenstein EL, Sketch MH Jr, et al. Economic impact of drug-eluting stents on hospital systems: a disease-state model. Am Heart J 2004;147:449-56.
-
(2004)
Am Heart J
, vol.147
, pp. 449-456
-
-
Kong, D.F.1
Eisenstein, E.L.2
Sketch Jr., M.H.3
-
8
-
-
21544456058
-
Cost-effectiveness of drug-eluting coronary artery stenting in a UK setting: Cost-utility study
-
in press
-
Bagust A, Grayson AD, Palmer ND, et al. Cost-effectiveness of drug-eluting coronary artery stenting in a UK setting: cost-utility study. Heart 2005: in press.
-
(2005)
Heart
-
-
Bagust, A.1
Grayson, A.D.2
Palmer, N.D.3
-
9
-
-
15844430483
-
One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: An analysis from the RAVEL trial
-
Van Hout BA, Serruys PW, Lemos PA, et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 2005;91:507-12.
-
(2005)
Heart
, vol.91
, pp. 507-512
-
-
Van Hout, B.A.1
Serruys, P.W.2
Lemos, P.A.3
-
10
-
-
13544260983
-
What reimbursement for coronary revascularization with drug-eluting stents?
-
Tarricone R, Marchetti M, Lamotte M, et al. What reimbursement for coronary revascularization with drug-eluting stents? Eur J Health Econ 2004;5:309-16.
-
(2004)
Eur J Health Econ
, vol.5
, pp. 309-316
-
-
Tarricone, R.1
Marchetti, M.2
Lamotte, M.3
-
11
-
-
21544457738
-
-
Hotline Vortrag, 2. April
-
Willich S, Brüggenjürgen B, McBride D, et al. Antiproliferative vs. konventionelle Stents: klinische und ökonomische Analysen einer kontrollierten Studie zur Vermeidung von Koronar-Restenosen. 71. Jahrestagung der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung, Hotline Vortrag, 2. April 2005.
-
(2005)
Antiproliferative Vs. Konventionelle Stents: Klinische und Ökonomische Analysen Einer Kontrollierten Studie Zur Vermeidung Von Koronar-Restenosen. 71. Jahrestagung der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung
-
-
Willich, S.1
Brüggenjürgen, B.2
McBride, D.3
-
13
-
-
21544440392
-
-
Presented at TCT, September 30, Washington, DC, USA
-
Dawkins K. TAXUS VI: 12-month clinical results. Presented at TCT, September 30,2004, Washington, DC, USA.
-
(2004)
TAXUS VI: 12-Month Clinical Results
-
-
Dawkins, K.1
-
14
-
-
0035979350
-
Clinical and economic impact of diabetes mellituson percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) trial
-
Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellituson percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001;104:533-8.
-
(2001)
Circulation
, vol.104
, pp. 533-538
-
-
Abizaid, A.1
Costa, M.A.2
Centemero, M.3
-
15
-
-
4143135288
-
Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease
-
Griffiths H, Bakhai A, West D, et al. Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease. Eur J Cardiothorac Surg 2004;26:528-34.
-
(2004)
Eur J Cardiothorac Surg
, vol.26
, pp. 528-534
-
-
Griffiths, H.1
Bakhai, A.2
West, D.3
-
16
-
-
0041355955
-
The Boston Scientific Antiproliferative, Paclitaxel Eluting Stents (TAXUS)
-
Serruys P, Kutryk M, eds. London: Dunitz
-
Silber S, Grube E. The Boston Scientific Antiproliferative, Paclitaxel Eluting Stents (TAXUS). In: Serruys P, Kutryk M, eds. Handbook of Coronary Stents, 4th edn. London: Dunitz, 2001:311-9.
-
(2001)
Handbook of Coronary Stents, 4th Edn.
, pp. 311-319
-
-
Silber, S.1
Grube, E.2
-
17
-
-
11144355008
-
Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation:a post hoc analysis of TAXUS II
-
Silber S, Hamburger J, Grube E, et al. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation:a post hoc analysis of TAXUS II. Herz 2004;29:171-80.
-
(2004)
Herz
, vol.29
, pp. 171-180
-
-
Silber, S.1
Hamburger, J.2
Grube, E.3
-
18
-
-
0042388295
-
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
-
Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-94.
-
(2003)
Circulation
, vol.108
, pp. 788-794
-
-
Colombo, A.1
Drzewiecki, J.2
Banning, A.3
-
19
-
-
9144249927
-
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
-
Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
-
(2004)
N Engl J Med
, vol.350
, pp. 221-231
-
-
Stone, G.W.1
Ellis, S.G.2
Cox, D.A.3
-
20
-
-
0037394555
-
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year outcomes
-
Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003;41:1293-304.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1293-1304
-
-
Hoffman, S.N.1
TenBrook, J.A.2
Wolf, M.P.3
-
21
-
-
0141954178
-
Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: One-year results from the Stent or Surgery trial
-
Zhang Z, Mahoney EM, Stables RH, et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation 2003;108:1694-700.
-
(2003)
Circulation
, vol.108
, pp. 1694-1700
-
-
Zhang, Z.1
Mahoney, E.M.2
Stables, R.H.3
-
22
-
-
20244377701
-
Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary linterventions of the European Society of Cardiology
-
Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary linterventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
-
(2005)
Eur Heart J
, vol.26
, pp. 804-847
-
-
Silber, S.1
Albertsson, P.2
Aviles, F.F.3
|